top of page


Alabama: News


January 23, 2020

Key Points: 

  • Connecticut’s vaping industry provided more than $341 million in economic activity in 2018 while generating 478 direct vaping-related jobs. Sales of disposables and prefilled cartridges in Connecticut exceeded $3.5 million in 2016.

  • As of January 17, 2020, CDPH has reported 46 cases of vaping-related lung illnesses, including one death. CDPH does not offer current cases counts with information on age, gender, or substances vaped. CDPH deserves a D for its transparency on vaping-related lung illnesses.  

  • In 2017, only 23.9 percent of Connecticut high school students cited flavors as a reason for e-cigarette use. More data is needed.  

  • Only 4 percent of FDA retail compliance checks in Connecticut resulted in sales of e-cigarettes to minors from January 1, 2018 to September 30, 2019.

  • Connecticut spends very little on tobacco prevention. In 2019, Connecticut dedicated $0 to tobacco control programs including education and prevention, despite receiving $459.6 million in tobacco settlement payments and taxes in the same year.


October 16, 2019
  • Lindsey Stroud examines reports by the Connecticut Department of Public Health (CDPH), finding the department is now omitting specific details about recent vaping-related hospitalizations.  

  • On August 21, 2019, CDPH reported two cases of vaping-related hospitalizations involving patients who admitted to vaping “both nicotine and marijuana products.

  • On September 19, CDPH confirmed 11 more cases, for a grand total of 13. Of these, CDPH interviewed nine patients, who all admitted “using vaping products containing tetrahydrocannabinol (THC), a psychoactive component of the marijuana plant.”

  • CDPH press releases on October 3 and October 11 did not mention anything about which substances individuals vaped prior to hospitalizations.

  • Recently, the Centers for Disease Control and Prevention (CDC) found a majority of vaping-related hospitalizations were due to vaping THC products. On October 3, CDC announced 78 percent of patients with vaping-related illnesses “reported using THC-containing products.” Similar results have been reported by health departments in Minnesota, Oregon, Texas, and Utah.

  • It is imperative lawmakers understand these illegal, unregulated THC-laden “vaping cartridges,” which are mostly homemade or available on the black market, are not e-cigarette products regulated by the U.S. Food and Drug Administration (FDA).

    • E-cigarettes and vaping devices first entered the U.S. market in 2007.

    • In 2012, FDA was granted authority to regulate vaping devices as tobacco products.

    • In 2016, FDA extended its regulatory authority over e-cigarettes, issuing deeming regulations. Under these rules, no new vaping product could come to market after August 8, 2016, without first completing a premarket tobacco application.

  • An estimated three million American adults have used vaping devices to quit smoking tobacco cigarettes. Further, e-cigarettes are twice as effective as nicotine replacement therapy in helping smokers quit.

  • In June June 2019, the American Cancer Society found “e-cigarette use [is] significantly less harmful for adults than smoking regular cigarettes […] because e-cigarettes do not contain or burn tobacco.”  

  • Making matters worse, far too many policymakers seek to reduce youth e-cigarette use, yet spend little tobacco revenue on such programs. 1998, Connecticut joined other sates in settling with tobacco companies in what became known as the Master Settlement Agreement (MSA).

bottom of page